News and Events
Stay up to date with news and events
Two birds, one stone: HTT-lowering drugs also target CAG expansions
Huntingtin (HTT)-lowering and somatic expansion have been two of the hottest topics in Huntington’s disease (HD) research in the past decade. Recent work from a…
Highlights from the 2024 CHDI HD Therapeutics Conference
Highlights from the 2024 CHDI HD Therapeutics Conference || Palm Springs 26 – 29 February 2024 Including Clinical Trial updates from PTC Therapeutics, Wave Life…
Hats off to brain donors on Brain Donation Awareness Day
If you’re a frequent reader of HDBuzz, you may have noticed that our articles increasingly thank Huntington’s disease (HD) families for their generous and selfless…
A sprinkling of good news for the treatment of HD chorea
We wrote in August of 2023 about the US approval of a new drug to treat chorea, the movement symptoms of HD. That drug, valbenazine,…
A new era for HDBuzz
HDBuzz strives to be an honest and neutral source of information that Huntington’s disease (HD) families can turn to for trusted, unbiased reporting on research…